Overview
Background
I am the Interim Director at The University of Queensland’s Centre for the Business and Economics of Health (CBEH). I also lead Health Technology Assessment for the Centre, which involves evaluating submissions made to the Australian Government to reimburse new medicines and medical devices through the Pharmaceutical Benefits Scheme (PBS) and the Medicare Benefits Schedule (MBS). My research is focused on the economic evaluation of health interventions to inform decision making and promote value-based health care. I have pioneered the application of Value of Information (Research) analysis to enhance the efficiency of clinical trials and maximise the return on investment from medical research.
I have extensive experience working with key stakeholders including consumers, clinicians, decision makers and researchers. I am chief investigator on over $40 million Category 1 grants from the NHMRC, MRFF and ARC. In addition, I lead several projects for the Department of Health and other peak organisations.
I chair the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)-Oncology Group, and I am the past chair of the Clinical Oncology Society of Australia's (COSA)-Epidemiology Group and the Australian Clinical Trials Alliance (ACTA)-Research Prioritisation Group. I am an Associate Editor for Value in Health, and an Editorial Board Member for Medical Decision Making and PharmacoEconomics-open journals.
Availability
- Professor Haitham Tuffaha is:
- Available for supervision
- Media expert
Fields of research
Research interests
-
Economic Evaluation of Healthcare Interventions
-
Health Technology Assessment
-
Value-Based Health Care
-
Cancer Economics
-
Medications use and safety
Research impacts
My research has significantly influenced health policy in Australia and internationally and was pivotal in the allocation of almost $1 billion in new drugs and medical technologies in Australia over the past ten years. My research program about evaluating new health technologies using Value of Information/implementation analyses led to a paradigm shift in the economic evaluation of new interventions and improved patient access to health innovations (e.g., genetic testing, targeted therapies). My research shifted the way clinical trials are prioritised and funded towards a value-based approach, which informed the development of the Australian Clinical Trials Alliance Research Prioritisation Framework.
I have published over 100 peer reviewed articles and technical reports for leading organisations, including 45 technical reports for the Australian Government on the economic evaluation of novel drugs, devices and services for a range of conditions including cancer, genetic testing, cardiovascular disease and liver disease.
Works
Search Professor Haitham Tuffaha’s works on UQ eSpace
2024
Journal Article
Economic evaluations of non-pharmacological interventions for treating disorders of gut-brain interaction: a scoping review
Pak, Anton, O'Grady, Madeline, Holtmann, Gerald, Shah, Ayesha and Tuffaha, Haitham (2024). Economic evaluations of non-pharmacological interventions for treating disorders of gut-brain interaction: a scoping review. PharmacoEconomics. doi: 10.1007/s40273-024-01455-y
2024
Journal Article
The cost-effectiveness of germline BRCA testing in metastatic prostate cancer followed by cascade testing of first-degree relatives of mutation carriers
Teppala, Srinivas, Scuffham, Paul, Edmunds, Kim, Roberts, Matthew J., Fairbairn, David, Smith, David P., Horvath, Lisa and Tuffaha, Haitham (2024). The cost-effectiveness of germline BRCA testing in metastatic prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. Value in Health, 27 (11), 1515-1527. doi: 10.1016/j.jval.2024.06.019
2024
Other Outputs
MSAC Application No. 1749.1 - Insertion of durable ventricular assist device (VAD) for use as destination therapy: Applicant Developed Assessment Report (ADAR)
Yeoh, S., Hettiarachchi, R. and Tuffaha, H. (2024). MSAC Application No. 1749.1 - Insertion of durable ventricular assist device (VAD) for use as destination therapy: Applicant Developed Assessment Report (ADAR). Canberra, ACT Australia: Commonwealth of Australia.
2024
Conference Publication
EV430/#358 Benefit-harm trade-off for groin node dissection versus groin ultrasound monitoring to reduce the risk of surgery-related morbidity in vulvar cancer – a decision-tree analysis
Obermair, Andreas, West, Zoe, Baxter, Eva, Condous, George, Hacker, Neville, Lord, Sally, Mccarthy, Sandie, Janda, Monika, Tuffaha, Haitham, Hayes, Sandi, Disipio, Tracey, Mellon, Anne, Gebski, Val, Mcnally, Orla and Martin, Andrew (2024). EV430/#358 Benefit-harm trade-off for groin node dissection versus groin ultrasound monitoring to reduce the risk of surgery-related morbidity in vulvar cancer – a decision-tree analysis. IGCS 2024 Annual Meeting, Dublin, Ireland, 16-18 October 2024. London, United Kingdom: BMJ Group. doi: 10.1136/ijgc-2024-igcs.551
2024
Journal Article
Modified Oral Health Assessment Tool (M-OHAT) for residential aged care: A co-design protocol
Ferris, Laura J., Ludlow, Kristiana, Walker, Nicole, Georgiou, Andrew, Henry, Julie D., Lopez Silva, Claudia, Ha, Diep H., Stormon, Nicole, Walsh, Laurence J., Ivanovski, Saso, Sexton, Christopher, Silveira Schuch, Helena, Tuffaha, Haitham, Zamora, Angelique, Pritchard, Lyndal and Do, Loc G. (2024). Modified Oral Health Assessment Tool (M-OHAT) for residential aged care: A co-design protocol. Healthcare, 12 (19) 1953, 1-10. doi: 10.3390/healthcare12191953
2024
Other Outputs
MSAC Application No. 1783 - Genetic testing to detect PIK3CA mutations in patients with hormone receptor (HR)-positive, HER-2 negative, locally advanced or metastatic breast cancer, to determine eligibility for treatment with PBS subsidised inavolisib: PICO Confirmation
Yeoh, S., Hettiarachchi, R. and Tuffaha, H. (2024). MSAC Application No. 1783 - Genetic testing to detect PIK3CA mutations in patients with hormone receptor (HR)-positive, HER-2 negative, locally advanced or metastatic breast cancer, to determine eligibility for treatment with PBS subsidised inavolisib: PICO Confirmation. Canberra, ACT Australia: Commonwealth of Australia.
2024
Other Outputs
MSAC Application No. 1593.1 - Bioinductive implant for the repair of rotator cuff tear: Applicant Developed Assessment Report (ADAR): Commonwealth of Australia
Hettiarachchi, Ruvini and Tuffaha, Haitham (2024). MSAC Application No. 1593.1 - Bioinductive implant for the repair of rotator cuff tear: Applicant Developed Assessment Report (ADAR): Commonwealth of Australia. Canberra, ACT Australia: Commonwealth of Australia.
2024
Journal Article
A preference-based value framework to assess healthcare provision in an oil and gas industry
Pak, Anton, Pols, Thomas, Kondalsamy-Chennakesavan, Srinivas, McGrail, Matthew, Gurney, Tiana, Fox, Jordan L. and Tuffaha, Haitham (2024). A preference-based value framework to assess healthcare provision in an oil and gas industry. Australian Health Review, 48 (5), 524-529. doi: 10.1071/ah24111
2024
Journal Article
Acceptability of a virtual prostate cancer survivorship care model in rural Australia: A multi-methods, single-centre feasibility pilot
Heneka, Nicole, Chambers, Suzanne K., Schaefer, Isabelle, Carmont, Kelly, Parcell, Melinda, Wallis, Shannon, Walker, Stephen, Tuffaha, Haitham, Steele, Michael and Dunn, Jeff (2024). Acceptability of a virtual prostate cancer survivorship care model in rural Australia: A multi-methods, single-centre feasibility pilot. Australian Journal of Rural Health, 32 (4), 815-826. doi: 10.1111/ajr.13149
2024
Journal Article
The cost-effectiveness of germline BRCA testing-guided olaparib treatment in metastatic castration resistant prostate cancer
Teppala, Srinivas, Scuffham, Paul A. and Tuffaha, Haitham (2024). The cost-effectiveness of germline BRCA testing-guided olaparib treatment in metastatic castration resistant prostate cancer. International Journal of Technology Assessment in Health Care, 40 (1) e14, e14. doi: 10.1017/s0266462324000011
2024
Journal Article
Prostate Cancer Survivorship Essentials for men with prostate cancer on androgen deprivation therapy: protocol for a randomised controlled trial of a tele-based nurse-led survivorship care intervention (PCEssentials Hormone Therapy Study)
Green, Anna, Newton, Robert U, Smith, David P, Tuffaha, Haitham, Galvão, Daniel A, Heathcote, Peter, Patel, Manish I, Christie, David, Egger, Sam, Sara, Sally AM, Heneka, Nicole, Chambers, Suzanne K and Dunn, Jeff (2024). Prostate Cancer Survivorship Essentials for men with prostate cancer on androgen deprivation therapy: protocol for a randomised controlled trial of a tele-based nurse-led survivorship care intervention (PCEssentials Hormone Therapy Study). BMJ Open, 14 (3) e084412, 1-9. doi: 10.1136/bmjopen-2024-084412
2024
Other Outputs
MSAC Application No. 1766 – Genetic testing to detect AKT-pathway alterations in patients with hormone receptor-positive, HER2-negative advanced breast cancer, to determine eligibility for PBS subsidised capivasertib treatment: PICO Confirmation
Yeoh, S., Hettiarachchi, R. and Tuffaha, H. (2024). MSAC Application No. 1766 – Genetic testing to detect AKT-pathway alterations in patients with hormone receptor-positive, HER2-negative advanced breast cancer, to determine eligibility for PBS subsidised capivasertib treatment: PICO Confirmation. Canberra, ACT, Australia: Commonwealth of Australia.
2024
Book Chapter
The expected value of perfect or partial perfect information
Jackson, Christopher, Jalal, Hawre, Heath, Anna, Kunst, Natalia, Thom, Howard, Welton, Nicky J., Tuffaha, Haitham and Wilson, Edward C. F. (2024). The expected value of perfect or partial perfect information. Value of information for healthcare decision-making. (pp. 47-91) edited by Anna Heath, Natalia Kuns and Christopher Jackson. Boca Raton, FL, United States: Chapman and Hall/CRC. doi: 10.1201/9781003156109-3
2024
Journal Article
Cost-effectiveness analysis of human papillomavirus vaccines for the prevention of cervical cancer in India
Arora, Shiksha and Tuffaha, Haitham (2024). Cost-effectiveness analysis of human papillomavirus vaccines for the prevention of cervical cancer in India. Asia-Pacific Journal of Clinical Oncology, 20 (1), 55-62. doi: 10.1111/ajco.13962
2024
Book Chapter
Value of information: success stories
Kunst, Natalia, Wilson, Edward C. F., Tuffaha, Haitham, Jackson, Christopher, Welton, Nicky J., Jalal, Hawre and Alarid-Escudero, Fernando (2024). Value of information: success stories. Value of information for healthcare decision-making. (pp. 193-206) edited by Anna Heath, Natalia Kuns and Christopher Jackson. Boca Raton, FL, United States: Chapman and Hall/CRC. doi: 10.1201/9781003156109-6
2024
Journal Article
Guidelines for genetic testing in prostate cancer: a scoping review
Tuffaha, Haitham, Edmunds, Kim, Fairbairn, David, Roberts, Matthew J., Chambers, Suzanne, Smith, David P, Horvath, Lisa, Arora, Shiksha and Scuffham, Paul (2024). Guidelines for genetic testing in prostate cancer: a scoping review. Prostate Cancer and Prostatic Diseases, 27 (4), 594-603. doi: 10.1038/s41391-023-00676-0
2024
Book Chapter
Value of information: success stories
Kunst, Natalia, Wilson, Edward C. F., Tuffaha, Haitham, Jackson, Christopher, Welton, Nicky J., Jalal, Hawre and Alarid-Escudero, Fernando (2024). Value of information: success stories. Value of information for healthcare decision-making. (pp. 193-205) edited by Anna Heath, Natalia Kunst and Christopher Jackson. Boca Raton, FL, United States: Taylor and Francis. doi: 10.1201/9781003156109
2023
Journal Article
Embedding stakeholder preferences in setting priorities for health research: Using a discrete choice experiment to develop a multi-criteria tool for evaluating research proposals
Taylor, William J., Tuffaha, Haitham, Hawley, Carmel M., Peyton, Philip, Higgins, Alisa M., Scuffham, Paul A., Nemeh, Fiona, Balagurunathan, Anitha, Hansen, Paul, Jacques, Angela and Morton, Rachael L. (2023). Embedding stakeholder preferences in setting priorities for health research: Using a discrete choice experiment to develop a multi-criteria tool for evaluating research proposals. PLoS One, 18 (12) e0295304, 1-12. doi: 10.1371/journal.pone.0295304
2023
Other Outputs
Emerging and adjunct treatments for common mental health conditions affecting veterans: a rapid evidence assessment
Maguire, Angela M., Soole, Rebecca, Beilby, Hannah, Tabinga, Angeli, Barker, Natalie, Fear, Nicola T., Kenardy, Justin, Tuffaha, Haitham and Khoo, Andrew (2023). Emerging and adjunct treatments for common mental health conditions affecting veterans: a rapid evidence assessment. Canberra, ACT Australia: Commonwealth of Australia.
2023
Journal Article
A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies
Modi, Natansh D., Kichenadasse, Ganessan, Hoffmann, Tammy C., Haseloff, Mark, Logan, Jessica M., Veroniki, Areti A., Venchiarutti, Rebecca L., Smit, Amelia K., Tuffaha, Haitham, Jayasekara, Harindra, Manning-Bennet, Arkady, Morton, Erin, McKinnon, Ross A., Rowland, Andrew, Sorich, Michael J. and Hopkins, Ashley M. (2023). A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies. BMC Medicine, 21 (1) 400, 400. doi: 10.1186/s12916-023-03113-0
Funding
Current funding
Supervision
Availability
- Professor Haitham Tuffaha is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Evaluation of Indonesian Chronic Diseases Management Program: Patients participation, adherence to the treatment and cost-effectiveness of the program
Principal Advisor
Other advisors: Associate Professor Adam La Caze, Dr Kim Edmunds
-
Doctor Philosophy
Assessing the Value for Money of Integrating Exercise as Therapy after Gynaecological Cancer Treatment
Principal Advisor
Other advisors: Professor Sandie McCarthy
-
Doctor Philosophy
Evaluation of Indonesian Chronic Diseases Management Program: Patients participation, adherence to the treatment and cost-effectiveness of the program
Principal Advisor
Other advisors: Associate Professor Adam La Caze, Dr Kim Edmunds
Completed supervision
-
2024
Doctor Philosophy
Assessing the Value for Money of Integrating Exercise as Therapy after Gynaecological Cancer Treatment
Principal Advisor
Other advisors: Professor Sandie McCarthy
Media
Enquiries
Contact Professor Haitham Tuffaha directly for media enquiries about:
- Cancer Economics
- Health Economics
- Health Services Research
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: